We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Welltower (WELL) Q2 FFO Surpasses Estimate, Revenue up Y/Y
Read MoreHide Full Article
Have you been eager to see how Welltower Inc. (WELL - Free Report) performed in Q2 in comparison with the market expectations? Let’s quickly scan through the key facts from this Toledo, OH-based, healthcare real estate investment trust’s (REIT) earnings release this morning.
FFO Beat
Welltower came out with normalized funds from operations (FFO) per share of $1, beating the Zacks Consensus Estimate of 99 cents.
How Was the Earnings Surprise Trend?
Welltower has a mixed earnings surprise history. Before posting a beat in Q2, the company delivered positive surprise in two out of prior four quarters, missed in other two occasions, as shown in the chart below. Overall, the company surpassed the Zacks Consensus Estimate by an average of 0.22% in the trailing four quarters.
Welltower posted revenues of nearly $1.13 billion, which beat the Zacks Consensus Estimate of $1.10 billion. It also compared favorably with the year-ago number of $1.06 billion.
Developments to Note
Welltower announced comprehensive restructuring of its Brookdale portfolio that enabled it to reduce its Brookdale concentration and increase lease coverage of its portfolio.
The company placed four development projects into service amounting to $89 million.
As such, the company raised its normalized FFO per share outlook to the range of $3.99-$4.06 from the previous range of $3.95-$4.05 for 2018. Also, the company anticipates its 2018 average blended same store net operating income growth of around 1-2%. Further, the company has increased its 2018 disposition proceeds projection to $2.4 billion from $1.9 billion guided earlier.
What Zacks Rank Says
Welltower has a Zacks Rank #3 (Hold). However, since the latest earnings performance is yet to be reflected in the estimate revisions, the rank is subject to change.
Note: Anything related to earnings presented in this write-up represents funds from operations (FFO) — a widely used metric to gauge the performance of REITs.
Check back later for our full write up on this WELL earnings report!
5 Medical Stocks to Buy Now
Zacks names 5 companies poised to ride a medical breakthrough that is targeting cures for leukemia, AIDS, muscular dystrophy, hemophilia, and other conditions.
New products in this field are already generating substantial revenue and even more wondrous treatments are in the pipeline. Early investors could realize exceptional profits.
Image: Bigstock
Welltower (WELL) Q2 FFO Surpasses Estimate, Revenue up Y/Y
Have you been eager to see how Welltower Inc. (WELL - Free Report) performed in Q2 in comparison with the market expectations? Let’s quickly scan through the key facts from this Toledo, OH-based, healthcare real estate investment trust’s (REIT) earnings release this morning.
FFO Beat
Welltower came out with normalized funds from operations (FFO) per share of $1, beating the Zacks Consensus Estimate of 99 cents.
How Was the Earnings Surprise Trend?
Welltower has a mixed earnings surprise history. Before posting a beat in Q2, the company delivered positive surprise in two out of prior four quarters, missed in other two occasions, as shown in the chart below. Overall, the company surpassed the Zacks Consensus Estimate by an average of 0.22% in the trailing four quarters.
Welltower Inc. Price and EPS Surprise
Welltower Inc. Price and EPS Surprise | Welltower Inc. Quote
Revenue Came In Higher Than Expected
Welltower posted revenues of nearly $1.13 billion, which beat the Zacks Consensus Estimate of $1.10 billion. It also compared favorably with the year-ago number of $1.06 billion.
Developments to Note
Welltower announced comprehensive restructuring of its Brookdale portfolio that enabled it to reduce its Brookdale concentration and increase lease coverage of its portfolio.
The company placed four development projects into service amounting to $89 million.
As such, the company raised its normalized FFO per share outlook to the range of $3.99-$4.06 from the previous range of $3.95-$4.05 for 2018. Also, the company anticipates its 2018 average blended same store net operating income growth of around 1-2%. Further, the company has increased its 2018 disposition proceeds projection to $2.4 billion from $1.9 billion guided earlier.
What Zacks Rank Says
Welltower has a Zacks Rank #3 (Hold). However, since the latest earnings performance is yet to be reflected in the estimate revisions, the rank is subject to change.
(You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.)
Note: Anything related to earnings presented in this write-up represents funds from operations (FFO) — a widely used metric to gauge the performance of REITs.
Check back later for our full write up on this WELL earnings report!
5 Medical Stocks to Buy Now
Zacks names 5 companies poised to ride a medical breakthrough that is targeting cures for leukemia, AIDS, muscular dystrophy, hemophilia, and other conditions.
New products in this field are already generating substantial revenue and even more wondrous treatments are in the pipeline. Early investors could realize exceptional profits.
Click here to see the 5 stocks >>